Treatment of PCOS patients with metformin improves menstrual irregularity and anovulation [239,240], resulting in inhibiting cytokine production, CYP19A1 (aromatase) activity, and endometrial cell proliferation [241]. The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.